Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
72.56%
operating margin TTM
20.01%
revenue TTM
259.25 Million
revenue per share TTM
1.63$
valuation ratios | |
|---|---|
| pe ratio | 9.36 |
| peg ratio | 0.09 |
| price to book ratio | 6.46 |
| price to sales ratio | 7.54 |
| enterprise value multiple | 33.53 |
| price fair value | 6.46 |
profitability ratios | |
|---|---|
| gross profit margin | 83.64% |
| operating profit margin | 20.01% |
| pretax profit margin | 17.43% |
| net profit margin | 72.56% |
| return on assets | 42.06% |
| return on equity | 101.12% |
| return on capital employed | 13.56% |
liquidity ratios | |
|---|---|
| current ratio | 4.10 |
| quick ratio | 3.29 |
| cash ratio | 0.51 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 454.56 |
| operating cycle | 635.57 |
| days of payables outstanding | 389.12 |
| cash conversion cycle | 246.44 |
| receivables turnover | 2.02 |
| payables turnover | 0.94 |
| inventory turnover | 0.80 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.25 |
| debt equity ratio | 0.40 |
| long term debt to capitalization | 0.28 |
| total debt to capitalization | 0.29 |
| interest coverage | 4.61 |
| cash flow to debt ratio | -0.10 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.17 |
| cash per share | 0.99 |
| operating cash flow per share | -0.17 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -0.10 |
| short term coverage ratios | -23.73 |
| capital expenditure coverage ratio | -115.76 |
Frequently Asked Questions
When was the last time TG Therapeutics, Inc. (NASDAQ:TGTX) reported earnings?
TG Therapeutics, Inc. (TGTX) published its most recent earnings results on 05-11-2025.
What is TG Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. TG Therapeutics, Inc. (NASDAQ:TGTX)'s trailing twelve months ROE is 101.12%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. TG Therapeutics, Inc. (TGTX) currently has a ROA of 42.06%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TGTX's net profit margin stand at?
TGTX reported a profit margin of 72.56% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TGTX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.10 in the most recent quarter. The quick ratio stood at 3.29, with a Debt/Eq ratio of 0.40.